[Compact therapy with 2 tablets daily. Initial triple combination tablet simplifies HIV therapy].
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015224:Dideoxynucleosides / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D004338:Drug Combinations; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage* / Q000009:adverse effects; D010349:Patient Compliance; D015215:Zidovudine / Q000008:administration & dosage* / Q000009:adverse effects; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D004338:Drug Combinations; D019259:Lamivudine; D015215:Zidovudine; C418262:abacavir, lamivudine, and zidovudine drug combination; D000099227:Abacavir